Cannabis Cultivation Cleared for Jammu Research

Permission for cannabis cultivation in Jammu and Kashmir has been secured, enabling scientific research into its medicinal properties. The initiative is moving towards pre-clinical trials for cannabis-based drug candidates, with collaboration established with Tata Memorial Centre in Mumbai. This project aims to develop export-quality medicines for various conditions, including neuropathies, cancer, epilepsy, and Acute Respiratory Distress Syndrome (ARDS).

The research is being conducted through a public-private partnership, including a French company, and is exclusively focused on the life-science applications of cannabis. Regulatory provisions ensure cultivation and utilization strictly for scientific and medical purposes. CSIR-IIIM has established protected cultivation facilities and a repository of over 500 cannabis accessions to support this pioneering research.

This development, permitted by the J&K government in 2017, represents a significant step in advancing scientific understanding of cannabis. The project holds potential for both economic and medicinal benefits, bringing together government bodies and private partners in a coordinated effort for societal advancement.